MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 111 filers reported holding MYOVANT SCIENCES LTD in Q4 2021. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $704,546 | -44.1% | 26,133 | -62.7% | 0.00% | -42.9% |
| Q3 2022 | $1,260,000 | +44.3% | 70,133 | -0.1% | 0.01% | +16.7% |
| Q2 2022 | $873,000 | -6.7% | 70,233 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $936,000 | -14.3% | 70,233 | +0.1% | 0.01% | -14.3% |
| Q4 2021 | $1,092,000 | -30.6% | 70,133 | 0.0% | 0.01% | -46.2% |
| Q3 2021 | $1,574,000 | +53.6% | 70,133 | +55.9% | 0.01% | +30.0% |
| Q2 2021 | $1,025,000 | +13.1% | 45,000 | +2.3% | 0.01% | 0.0% |
| Q1 2021 | $906,000 | -23.4% | 44,000 | +2.8% | 0.01% | -37.5% |
| Q4 2020 | $1,182,000 | +111.1% | 42,790 | +6.9% | 0.02% | +77.8% |
| Q3 2020 | $560,000 | +15.7% | 40,040 | +66.6% | 0.01% | +12.5% |
| Q2 2020 | $484,000 | +229.3% | 24,040 | +20.2% | 0.01% | +166.7% |
| Q1 2020 | $147,000 | -50.2% | 20,000 | 0.0% | 0.00% | -40.0% |
| Q4 2019 | $295,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
| Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
| VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
| Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
| Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
| Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
| Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
| Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
| Matisse Capital | 32,750 | $508,000 | 0.36% |
| VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |